A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

Status Not yet recruiting

Clinical Trial Summary

The purposes of this study are 1) to determine if the administration of different low doses of CBD (5 mg, 17 mg, 50 mg and 100 mg) result in detectable subjective pleasant drug effect compared to placebo and 2) to qualitatively explore whether low dose CBD is associated with effects that are not detected with the available research tools.

Clinical Trial Description

Cannabis contains over 100 cannabinoids, the two most prominent being Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). A growing body of evidence exists surrounding the effects of both THC and CBD, however, less is known about the specific effects of CBD concentrations alone. Most existing data regarding the effects of CBD come from studies where this compound is administered in high doses in a therapeutic context, and where the subject can be administered either CBD, THC or both together. These contexts are not representative of the current use by many consumers. Indeed, several available products contain CBD at much lower doses. The overall objective of this study is to evaluate the acute behavioral and biological effects of low doses of CBD (between 5-100mg) and placebo in occasional cannabis users. Potential outcomes not detected with usual assessment tools designed to evaluate THC-induced effects will also be explored. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05320367
Study type	Interventional
Source	Centre hospitalier de l'Université de Montréal (CHUM)
Contact	Pamela Lachance, PhD
Phone	514-890-8000
Email	pamela.lachance-touchette.chum@ssss.gouv.qc.ca
Status	Not yet recruiting
Phase	Phase 1/Phase 2
Start date	October 2024
Completion date	November 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Completed	`NCT04199468` - THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis	Phase 1
Completed	`NCT04587700` - Analgesic Consumption in Chronic Marijuana Users Following Orthopedic Trauma Surgery
Not yet recruiting	`NCT05899946` - An Integrated Program to Promote Anti-cannabis Messages	N/A
Active, not recruiting	`NCT02735954` - Colorado Marijuana Users Health Cohort
Completed	`NCT00842985` - Dronabinol Interactions in Humans	N/A
Completed	`NCT04124432` - Behavioral Pharmacology of Cannabis and Nicotine	Phase 1
Active, not recruiting	`NCT04693884` - Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise	Early Phase 1
Recruiting	`NCT03078309` - The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients	Early Phase 1
Active, not recruiting	`NCT03560934` - Tetrahydrocannabinol (THC) and Sleep	Early Phase 1
Recruiting	`NCT04704271` - Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II	Phase 1
Withdrawn	`NCT03245658` - The Effect of Cannabis in Pancreatic Cancer	Phase 2
Completed	`NCT04911127` - Therapeutic Response of Cannabidiol in Rheumatoid Arthritis	Phase 1/Phase 2
Not yet recruiting	`NCT05999383` - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration	Phase 2
Recruiting	`NCT04429568` - THC Crossover Study	N/A
Active, not recruiting	`NCT05554146` - Pain Inflammation and Cannabis in HIV	N/A
Completed	`NCT02567344` - Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving	N/A
Terminated	`NCT03251326` - Nabilone in Cannabis Users With PTSD	Phase 1/Phase 2
Completed	`NCT00176085` - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH	Phase 1
Enrolling by invitation	`NCT06235632` - Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers	N/A